Cargando…
cfDNA screening and diagnosis of monogenic disorders – where are we heading?
Cell‐free fetal DNA analysis for non‐invasive prenatal screening of fetal chromosomal aneuploidy has been widely adopted for clinical use. Fetal monogenic diseases have also been shown to be amenable to non‐invasive detection by maternal plasma DNA analysis. A number of recent technological developm...
Autores principales: | Chiu, Eunice Ka Long, Hui, Winnie Wai In, Chiu, Rossa Wai Kwun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839244/ https://www.ncbi.nlm.nih.gov/pubmed/29314147 http://dx.doi.org/10.1002/pd.5207 |
Ejemplares similares
-
Opening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing
por: Horn, Ruth, et al.
Publicado: (2017) -
Diagnosis of lethal or prenatal‐onset autosomal recessive disorders by parental exome sequencing
por: Stals, Karen L., et al.
Publicado: (2017) -
Breast Implant Surfaces and Their Impact on Current Practices: Where We Are Now and Where Are We Going?
por: Munhoz, Alexandre Mendonça, et al.
Publicado: (2019) -
Microfluidic Technologies for cfDNA Isolation and Analysis
por: Xu, Zheyun, et al.
Publicado: (2019) -
Cardioneuroablation: Where are we at?
por: Pachon, Jose Carlos, et al.
Publicado: (2023)